Oliver Hasler, executive chairman of PYX Resources, presents 1H24 Results. Watch the interview here.

Less Ads, More Data, More Tools Register for FREE
Sponsored Content
Sponsored Content

Pin to quick picksPoolbeg Pharma Share News (POLB)

Share Price Information for Poolbeg Pharma (POLB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 10.60
Bid: 10.50
Ask: 10.70
Change: -0.30 (-2.75%)
Spread: 0.20 (1.905%)
Open: 10.80
High: 10.80
Low: 10.60
Prev. Close: 10.90

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EARNINGS AND TRADING: Man Group profit rises; Petershill AUM increases

Fri, 26th Jul 2024 18:59

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

----------

Keywords Studios PLC - provider of technical and creative services for video game production - Provides trading update for 2024 to date. Remains confident in delivering good overall revenue growth in 2024, with performance expected to be second half weighted as the sector starts to emerge from the slower content creation trends that are currently dampening industry spend and therefore Keywords' growth. But notes a small number of larger game development projects have been deferred or cancelled in the first half. This, together with ongoing softer demand in Globalize and the relatively slow ramp-up in content production in Hollywood, has meant that reported revenue is expected to grow by around 7% in the first half, with organic growth expected to be around minus 2%. First half adjusted operating margins seen around 13%. Notes pipeline of of active M&A opportunities.

----------

Hipgnosis Songs Fund Ltd - London-based music investment company - Court sanctions scheme by which bid by Blackstone Inc will be implemented. Scheme expected to become effective on Monday. Shares expected to be suspended on Monday.

----------

Supermarket Income REIT PLC - London-based real estate investment trust - Completes GBP170 million refinancing through its first private placement debt issuance and a new unsecured bank facility. Signs and completes an agreement with a group of institutional investors for a private placement of EUR83 million of new senior unsecured notes. The notes have a maturity of seven years and a fixed rate coupon of 4.44%. Also refinances existing GBP97 million secured debt facility with Deka through a new GBP100 million unsecured debt facility with ING Bank NV.

----------

Petershill Partners PLC - London-based investment group focussed on private equity and other private capital strategies - Aggregate partner-firm assets under management rise 11% to USD332 billion from a year prior. At June 30, partner-firms had USD8 billion of AUM which is not yet paying fees, similar to the level at December 31 2023.

----------

Man Group PLC - London-based active investment manager focused on private markets - In the six months to June 30, pretax profit rises to USD164 million from USD83 million a year prior. Core net revenue rises to USD761 million from USD513 million, earnings per share climb to 17.1 US cents from 8.9 cents. Assets under management June 30 is USD178.2 billion from USD167.5 billion on December 31. Notes net inflows of USD0.9 billion, positive investment performance of USD11.1 billion. Declares 5.6 cents interim dividend, as guided and unchanged from a year ago. Says "business is in great shape" going into the second half. "We have started the year strongly, delivering for our clients in a market environment driven by the evolution of forward interest rates, expectations of technological disruption, and the outcome of elections globally," company says.

----------

GCP Infrastructure Investments Ltd - Jersey-based investment company, which is focused on infrastructure - Net asset value per share at June 30 is 107.58 pence, down slightly from 107.62 pence at March 31. The portfolio continues to perform materially in line with the company's expectations.

Announces a dividend of 1.75 pence per share for April to June, in line with the annual dividend target of 7p per ordinary share.

----------

Jupiter Fund Management PLC - London-based "high-conviction" active asset manager - In the six months to June 30 pretax profit grows 11% to GBP38.7 million from GBP34.8 million a year prior. Net revenue, however, falls to GBP173.7 million from GBP181.0 million. Basic earnings per share are 5.4 pence, up from 4.6p. Total dividend is cut to 3.2p from 6.4p. Discloses outflow of GBP3.4 billion in the period. Assets under management little changed at GBP51.3 billion. "Jupiter delivered a solid financial performance during the first half of the year consistent with our expectations despite experiencing outflows, which were nearly all associated with changes in the Value team and to the management of the Chrysalis Investment Trust," company says. Sees reasons to be "cautiously optimistic".

----------

Poolbeg Pharma PLC - London-based clinical-stage biopharmaceutical company - Announces it is voluntarily delisting its ordinary shares from trading on the OTCQB market due to low trading volume and associated administrative requirements. Last day of trading will be Monday. Reaffirms its ambitions to be dual listed on a national securities exchange in the US, such as Nasdaq, subject to meeting their listing requirements at the appropriate time.

----------

EQTEC PLC - Cork, Ireland-based thermochemical conversion technology company - Confirms the acquisition of two lots of property in Castiglione d'Orcia, Italy that houses the EQTEC Italia MDC plant and feedstock storage facilities. Pays EUE0.6 million cash.

----------

ACG Acquisition Co Ltd - special purpose acquisition company focused on new economy metals mining - Extends deadline by Class A shareholders wish to redeem all or a portion of their depositary interests to August 13 from July 30.

----------

Great Southern Copper PLC - Chile-focused copper, gold, and lithium explorer - In the year to March 31, pretax loss widens to GBP1.8 million from GBP1.3 million. Loss per shares improves to 0.64 pence from 0.61p. "The next six to twelve months promise to be an exciting period for the company with plans in place to drill our priority targets. Our strengthened financial position enables us to accelerate our exploration activities, ensuring that we maximise the value of our asset base," company says.

----------

Jadestone Energy PLC - Asia-Pacific focused upstream oil and gas company - Announces that through the Malaysia bid round plus it has been awarded a 100% participating interest in a small field asset production sharing contract offshore peninsular Malaysia by Petroliam Nasional Berhad.

----------

Oberon Investments Group PLC - investment management, wealth planning and corporate broking firm - In the year to March 31, revenue increases by 50% to GBP7.58 million from GBP5.05 million last year. Group loss narrows to GBP2.7 million from GBP3.9 million. Says activity levels continue to grow at a rapid pace in the first quarter following several new initiatives and client wins. Growth is expected to continue in financial 2025, with target revenue growth of more than 30% on a like-for-like basis. On track to move towards profitability in the second half of financial 2025, barring exceptional costs.

----------

Trident Royalties PLC - diversified mining royalty company - Court meeting approves scheme by which bid by Deterra Global Holdings Pty Ltd will be implemented.

----------

Panthera Resources PLC - gold exploration and development company owning multiple assets across West Africa and India - Australian subsidiary Indo Gold Pty Ltd formally issued a notice of arbitration with the Republic of India over the latter's breaches of its obligations under the 1999 Agreement between the Government of Australia and the Government of the Republic of India on the Promotion and Protection of Investments.

----------

By Jeremy Cutler, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
6 Jun 2024 14:52

UK shareholder meetings calendar - next 7 days

Friday 7 June 
Property Franchise Group PLCAGM
Trident Royalties PLCAGM
TruSpine Technologies PLCAGM
Monday 10 June 
Aterian PLCAGM
Griffin Mining LtdAGM
Lok'n Store Group PLCGM re takeover by Shurgard
Onward Opportunities LtdAGM
Oxford Nanopore Technologies PLCAGM
Pan African Resources PLCGM re capital reduction
Tuesday 11 June 
Ebiquity PLCAGM
Flowtech Fluidpower PLCAGM
MaxCyte IncAGM
Mobico Group PLCAGM
Newbury Racecourse PLCAGM
Nightcap PLCGM re fundraise
Phoenix Digital Assets PLCGM re up to GBP33.7 million fundraise
Tirupati Graphite PLCGM requisitioned by Walpole St Andrews Nominees
Tortilla Mexican Grill PLCAGM
Tufton Oceanic Assets LtdEGM
Wednesday 12 June 
Advanced Medical Solutions Group PLCAGM
Alina Holdings PLCAGM
Aquila Energy Efficiency Trust PLCAGM
Aurora Investment Trust PLCAGM
BioPharma Credit PLCAGM
Brighton Pier Group PLCAGM
Digital 9 Infrastructure PLCAGM
EPE Special Opportunities LtdAGM
Foresight Solar Fund LtdAGM
Star Energy Group PLCAGM
Thursday 13 June 
Beacon Rise Holdings PLCAGM
Christie Group PLCAGM
Everyman Media Group PLCAGM
Hochschild Mining PLCAGM
Iofina PLCAGM
Jadestone Energy PLCAGM
Panther Metals PLCAGM
Pollen Street Group LtdAGM
Poolbeg Pharma PLCAGM
Serabi Gold PLCAGM
Smurfit Kappa Group PLCGM re WestRock deal
Sound Energy PLCAGM
Starwood European Real Estate Finance LtdAGM
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
1 May 2024 16:39

Poolbeg Pharma celebrates full patent approval for Immunomodulator II

(Alliance News) - Poolbeg Pharma PLC on Wednesday said that it has received a fully granted patent from the US Patent Office for its Immunomodulator II patent application.

Read more
30 Apr 2024 16:43

Poolbeg agrees 12-month option over potential Behcet's treatment

(Sharecast News) - Poolbeg Pharma announced an exclusive 12-month option agreement with Silk Road Therapeutics on Tuesday, to potentially acquire a novel topical muco-adherent formulation of Pentoxifylline (tPTX).

Read more
30 Apr 2024 16:30

EARNINGS: Avacta sales jump; Poolbeg loss narrows; Digital 9 NAV down

(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
20 Mar 2024 16:18

EARNINGS AND TRADING: Roadside Real Estate trims Cambridge Sleep stake

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
20 Mar 2024 11:10

Poolbeg Pharma to be granted US patent

(Sharecast News) - Biopharmaceutical company Poolbeg Pharma announced on Wednesday that it has received a notice of allowance from the US Patent Office regarding its immunomodulator II patent application.

Read more
19 Feb 2024 14:22

Director dealings: Poolbeg Pharma co-founder ups stake

(Sharecast News) - Poolbeg Pharma revealed on Monday that chairman Cathal Friel had acquired 830,000 ordinary shares in the AIM-listed biopharmaceutical company.

Read more
15 Feb 2024 16:02

TRADING UPDATES: Diversified Energy offers dividend alternative

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
12 Feb 2024 19:44

TRADING UPDATES: Katoro Gold launches fundraising, eyes board shake-up

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
12 Feb 2024 14:37

Poolbeg upbeat on research into potential drug market

(Sharecast News) - Biopharmaceutical company Poolbeg Pharma announced findings from independent research confirming a substantial market opportunity exceeding $10bn for its drug candidate POLB 001 on Monday, in preventing cancer immunotherapy-induced cytokine release syndrome (CRS) through oral delivery.

Read more
17 Jan 2024 13:58

Poolbeg Pharma hails POLB 001'S potential to treat CRS

(Alliance News) - Poolbeg Pharma PLC on Wednesday noted "promising" results for POLB 001's potential in treating cancer immunotherapy-induced cytokine release syndrome.

Read more
20 Dec 2023 20:00

TRADING UPDATES: K3 Business says cash balances ahead of forecast

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
20 Dec 2023 13:54

Poolbeg makes promising progress with RSV programme

(Sharecast News) - Poolbeg Pharma revealed promising results from the lab-based analysis and prioritisation of respiratory syncytial virus (RSV) drug targets and treatments on Wednesday, driven by its artificial intelligence (AI) programme.

Read more
21 Nov 2023 14:39

TRADING UPDATES: Poolbeg hails approval; EDX links with Thermo Fisher

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more

Make Better Investment Decisions

Register for FREE

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.